Enhanced Cartilage Defect Repair System

A novel system for repairing cartilage defects, comprising a biocompatible scaffold, a composition of cultured allogeneic cells and a resorbable collagen membrane, and optional bioactive molecules and growth factors to enhance integration and tissue remodeling.

The original patent addresses the limitation of spontaneous repair of chondral lesions, but it has inherent limitations in terms of integration with surrounding tissue and long-term efficacy. The new inventive concept addresses these limitations by incorporating a biocompatible scaffold, bioactive molecules, and growth factors to enhance the repair process.

The system consists of a biocompatible scaffold with a microstructure designed to promote cell growth and differentiation. The scaffold is configured to enhance the integration of the composition with the surrounding tissue. The composition comprises cultured allogeneic cells and a resorbable collagen membrane. Optional bioactive molecules and growth factors can be applied to the defect site to promote cell recruitment and differentiation, and to enhance the repair process. The system can be personalized using computer-aided design to generate a customized scaffold based on patient-specific defect geometry.

The new claims introduce a biocompatible scaffold and optional bioactive molecules and growth factors, which are not present in the original patent. These components enhance the integration of the composition with the surrounding tissue and promote tissue remodeling, resulting in a more effective and long-lasting repair.

Alternative embodiments of the system could include different types of biocompatible scaffolds, such as nanofibrous or hydrogel-based scaffolds. The composition could also be modified to include different types of cells or biomolecules. Additionally, the system could be adapted for use in repairing defects in other tissues, such as bone or skin.

The enhanced cartilage defect repair system has significant commercial potential in the orthopedic and sports medicine industries, where there is a high demand for effective and long-lasting treatments for cartilage defects. The system could also be marketed for use in veterinary medicine to treat cartilage defects in animals.